158 recalls tagged with “workplace”.
B. Braun Medical recalled 15,250 PB1500 15-DROP IV SETS distributed worldwide, including the US, Canada, Germany, Guatemala and Singapore. The devices pose a backflow risk from secondary IV containers into primary containers and may fail to prime. Healthcare facilities should stop using the product and follow recall instructions.
BBMI recalled 63,192 IV administration sets worldwide on Oct 29, 2025. The recall affects the IV administration set labeled as 490426 with UDIs listed. The defect is potential backflow from secondary to primary IV containers and an inability to prime. Patients and healthcare providers should stop using these devices immediately and follow the manufacturer’s recall instructions.
B. Braun Medical recalls 286,400 IV administration sets used with Infusomat Space Large Volume Pump, Outlook Pump and Vista Basic Pump worldwide. The devices may backflow from secondary IV containers into primary containers and cannot be primed. Stop using the device immediately and follow recall instructions from the manufacturer.
B Braun Medical recalled 41,976 IV Administration Sets sold worldwide after identifying a backflow risk. The device can allow medication to flow from secondary (piggyback) containers into the primary IV line and may not prime properly. Hospitals and healthcare providers should stop using the sets immediately and await recall instructions from B Braun Medical.
B. Braun Medical Inc. recalled 5,952 IV Administration Sets distributed worldwide, including the US, Canada, Germany, Guatemala and Singapore, for use with Infusomat Space, Outlook, and Vista Basic Pumps. The units carry Catalog Number 490612. The recall cites potential backflow from secondary piggyback IV containers into primary containers and an inability to prime. Hospitals and healthcare teams
B. Braun Medical recalled 122,232 IV administration sets sold worldwide through multiple medical distributors. The devices have a backflow risk from secondary (piggyback) IV containers into primary IV containers and may fail to prime. Hospitals and clinics should stop using the sets and follow the manufacturer's recall instructions.
B Braun Medical recalled 24,624 Blood Administration Sets worldwide. The recall covers sets used with Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. The risk involves backflow from secondary IV containers into primary containers and the inability to prime. Hospitals and clinics should stop using the devices immediately and follow recall instructions.
B. Braun Medical recalled 7,344 Blood Administration Sets used with Infusomat Space, Outlook Pump, and Vista Basic Pump. The devices may allow backflow from secondary (piggyback) IV containers into primary IV containers and cannot be primed. Hospitals and healthcare providers should stop using the devices immediately and follow manufacturer instructions.
B. Braun Medical Inc. recalls 31,392 IV administration sets used with Infusomat Space and other pumps worldwide. The device may allow backflow from piggyback containers into primary IV lines and cannot be primed. Hospitals and healthcare providers should stop using the device immediately and follow recall instructions.
B Braun Medical recalled 4,488 IV administration sets distributed worldwide, including the United States, Canada, Germany, Guatemala and Singapore. The devices risk backflow from secondary (piggyback) IV containers into primary containers and may be unable to prime due to occlusion. Healthcare facilities and patients should stop using immediately and follow recall instructions from the maker.
B. Braun Medical recalled 33,528 Blood Administration Set units used with Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. The sets have a backflow risk from secondary piggyback IV containers into primary IV containers and may fail to prime. Health-care facilities should stop using the device immediately and follow the recall letter instructions.
B. Braun Medical recalled 46,250 SAFELINE IV sets sold worldwide on Oct. 29, 2025. The devices pose a backflow risk from secondary piggyback IV containers into primary lines and may fail to prime due to occlusion. Hospitals and patients using Infusomat Space Large Volume Pump, Outlook Pump, or Vista Basic Pump with SAFELINE sets should stop use immediately and await manufacturer instructions.
B Braun Medical recalled 11,832 IV administration sets worldwide on Oct 29, 2025. The devices are used with Infusomat Space, Outlook, and Vista Basic Pumps. The hazard is backflow of medication and occlusion. Stop using the product immediately and follow manufacturer recall instructions. Check your model numbers and contact the manufacturer for refunds or replacements.
One unit of the Siemens MAMMOMAT Fusion operator table is recalled after being sold with a bus-installation kit. The device is not intended for bus installations and is designed for stationary operation. Health care providers should stop using the device immediately and follow the manufacturer’s recall instructions.
3M and its Scotch brand recalled the TL909-50 thermal laminator sold at Office Depot, Office Smart and School Specialty from August 2024 through September 2025. The units may overheat, creating a burn hazard. Consumers should stop using the recalled laminator, unplug it and contact 3M for a full refund.
Mindray DS USA recalled 148 Sevoflurane V90 electronic vaporizers used with the A9 Anesthesia System. The devices have a potential for anesthesia leakage. Healthcare facilities should stop using the device immediately and follow manufacturer instructions.
Mindray DS USA recalled 54 Isoflurane V90 Vaporizers used with the A9 Anesthesia System, distributed worldwide to healthcare providers. The devices have a potential for anesthesia leakage. Clinicians should stop using immediately and contact Mindray DS USA for instructions.
M.C.I. Foods recalled 1,040 cases of ready-to-eat Egg and Cheese Breakfast Burritos and Wraps sold to seven distributors nationwide for institutional use. A cooked egg ingredient used in the ready-to-eat products tested positive for Listeria monocytogenes. Consumers should not consume the product and should contact M.C.I. Foods for refund or replacement; notification will be by letter.
Camber Pharmaceuticals recalled Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL single-dose vials distributed nationwide in the United States. The recall is due to the presence of glass particulates. Healthcare providers and patients should stop using the product immediately and contact Aspiro Pharma Limited at 1-866-495-1995 for guidance.
BD recalled 177 units of the BACTEC Blood Culture System worldwide after an unauthorized actor accessed product service credentials. The breach could allow unauthorized access to system configurations and data. Healthcare facilities should stop using the affected equipment and follow BD’s recall instructions.